SSTR	Somatostatin receptor
NET	Neuroendocrine tumor
SRS	Somatostatin receptor scintigraphy
SSTR-PET	Somatostatin receptor positron-emission tomography
PET	Positron-emission tomography
SUV	Standardized uptake value
MRI	Magnetic resonance imaging
CT	Computed tomography
PRRT	Peptide radionuclide receptor therapy
PSMA	Prostate-specific membrane antigen
SRE-TV	Somatostatin receptor-expressing tumor volume
PFS	Progression-free survival
OS	Overall survival
SSA	Somatostatin analogs
FDG	Fluorodeoxyglucose
MTV	Metabolic tumor volume
PERCIST	PET response criteria in solid tumors
SD	Standard deviation
SUVmax	Maximum standardized uptake value
SUVmean	Mean standardized uptake value
pNET	Pancreatic neuroendocrine tumor
TLR	Tumor-to-liver ratio
IBI	Inflammation-based index
G1/2/3	Grade 1/2/3
CA9	Cancer antigen 9
GLUT1	Glucose transporter 1
Gy	Gray
5-FU	5-fluorouracil
PROMISE	Prostate cancer molecular imaging standardized evaluation
TNM	Tumor node metastasis
PPP	PSMA PET progression criteria
RECIP	Response evaluation using PSMA PET/CT in patients with metastatic castration-resistant prostate cancer